Arcus Biosciences RCUS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arcus Biosciences's net change in cash?
- Arcus Biosciences (RCUS) reported net change in cash of -$21M in Q1 2026.
- How has Arcus Biosciences's net change in cash changed year-over-year?
- Arcus Biosciences's net change in cash decreased by 150.0% year-over-year, from $42M to -$21M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.